Boost for BTG as Campath moves into PhIII for MS
Pharma Times (subscription) - London,UK
British-based BTG received more good news this week regarding Campath after its licensee, Genzyme Corp, and Bayer Schering Pharma AG announced they had ...
See all stories on this topic

New Zealand backing for Tysabri
RTE.ie - Ireland
Elan and partner Biogen said today their drug Tysabri has been approved in New Zealand for treatment of the relapsing remitting form of multiple sclerosis. ...
See all stories on this topic

What are CFDs
Irish Independent - Dublin,Ireland
... a favourite CFD punt among Irish investors, plummeted after it temporarily withdrew its Tysabri multiple sclerosis treatment from the market.
See all stories on this topic

Health BRIEFS
McKinney Courier-Gazette Fri, 28 Sep 2007 11:12 PM PDT
The Multiple Sclerosis Support Group will meet at 7 p.m. Monday at the Medical Center of McKinney Wysong Campus, 130 S. Central Expressway, in Classroom 1.